EUVIMEDEUVIMED entdecken
Open Access

Cardiomyocyte PANX1 Controls Glycolysis and Neutrophil Recruitment in Hypertrophy

Caitlin M Pavelec iD, Alexander P Young, Hannah L Luviano, Emily E Orrell iD, Anna Szagdaj, Nabin Poudel iD, Abigail G Wolpe, Samantha H Thomas, Scott Yeudall iD, Clint M Upchurch iD, Mark D Okusa iD, Brant E Isakson iD und 2 weitere

Circulation Research · 02.08.2024 · 135 (4) · 503-517

DOI: 10.1161/circresaha.124.324650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, erschienen am 02.08.2024. Verfasst von Caitlin M Pavelec und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology (C.M.P., H.L.L., E.E.O., A.S., S.H.T., S.Y., C.M.U., N.L.), University of Virginia School of Medicine, Charlottesville. Hauptthemen laut MEDLINE: Connexins, Glycolysis, Myocytes, Cardiac, Nerve Tissue Proteins. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: PANX1 (pannexin 1), a ubiquitously expressed ATP release membrane channel, has been shown to play a role in inflammation, blood pressure regulation, and myocardial infarction. However, the possible role of PANX1 in cardiomyocytes in the progression of heart failure has not yet been investigated. METHOD: We generated a novel mouse line with constitutive deletion of PANX1 in cardiomyocytes (Panx1 MyHC6 ). RESULTS: PANX1 deletion in cardiomyocytes had no effect on unstressed heart function but increased the glycolytic metabolism and resulting glycolytic ATP production, with a concurrent decrease in oxidative phosphorylation, both in vivo and in vitro. In vitro, treatment of H9c2 (H9c2 rat myoblast cell line) cardiomyocytes with isoproterenol led to PANX1-dependent release of ATP and Yo-Pro-1 uptake, as assessed by pharmacological blockade with spironolactone and siRNA-mediated knockdown of PANX1. To investigate nonischemic heart failure and the preceding cardiac hypertrophy, we administered isoproterenol, and we demonstrated that Panx1 MyHC6 mice were protected from systolic and diastolic left ventricle volume increases as a result of cardiomyocyte hypertrophy. Moreover, we found that Panx1 MyHC6 mice showed decreased isoproterenol-induced recruitment of immune cells (CD45 + ), particularly neutrophils (CD11b + [integrin subunit alpha M], Ly6g + [lymphocyte antigen 6 family member G]), to the myocardium. CONCLUSIONS: Together, these data demonstrate that PANX1 deficiency in cardiomyocytes increases glycolytic metabolism and protects against cardiac hypertrophy in nonischemic heart failure at least in part by reducing immune cell recruitment. Our study implies PANX1 channel inhibition as a therapeutic approach to ameliorate cardiac dysfunction in patients with heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConnexinsGlycolysisMyocytes, CardiacNerve Tissue ProteinsNeutrophil InfiltrationAnimalsRatsMiceIsoproterenolCardiomegalyMice, Inbred C57BLCell LineMaleAdenosine TriphosphateMice, KnockoutHeart Failure

Stichwörter der Autor:innen

heart failuremacrophagesneutrophilsprevalencestroke volume

Substanzen

ConnexinsPanx1 protein, mouseNerve Tissue ProteinsIsoproterenolAdenosine Triphosphate

Autor:innen und Institutionen

  • Department of Pharmacology (C.M.P., H.L.L., E.E.O., A.S., S.H.T., S.Y., C.M.U., N.L.), University of Virginia School of Medicine, Charlottesville.
  • Robert M. Berne Cardiovascular Research Center (C.M.P., A.P.Y., B.E.I., M.J.W., N.L.), University of Virginia School of Medicine, Charlottesville.
  • Cardiovascular Medicine, Department of Medicine (A.P.Y., M.J.W.), University of Virginia School of Medicine, Charlottesville.
  • Division of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine (N.P., M.D.O.), University of Virginia School of Medicine, Charlottesville.
  • Department of Cell Biology (A.G.W.), University of Virginia School of Medicine, Charlottesville.
  • Department of Molecular Physiology and Biological Physics (B.E.I.), University of Virginia School of Medicine, Charlottesville.

ORCID-Profile: Caitlin M Pavelec, Emily E Orrell, Nabin Poudel, Scott Yeudall, Clint M Upchurch, Mark D Okusa, Brant E Isakson, Matthew J Wolf, Norbert Leitinger

Förderung

  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Pavelec, C. M., Young, A. P., Luviano, H. L., Orrell, E. E., Szagdaj, A., Poudel, N., Wolpe, A. G., Thomas, S. H., Yeudall, S., Upchurch, C. M., Okusa, M. D., Isakson, B. E., Wolf, M. J., & Leitinger, N. (2024). Cardiomyocyte PANX1 Controls Glycolysis and Neutrophil Recruitment in Hypertrophy. Circulation Research, 135(4), 503-517. https://doi.org/10.1161/circresaha.124.324650

Vancouver

Pavelec CM, Young AP, Luviano HL, Orrell EE, Szagdaj A, Poudel N, et al. Cardiomyocyte PANX1 Controls Glycolysis and Neutrophil Recruitment in Hypertrophy. Circulation Research. 2024;135(4):503-517. doi:10.1161/circresaha.124.324650

BibTeX
@article{Pavelec2024,
  author = {Pavelec, Caitlin M and Young, Alexander P and Luviano, Hannah L and Orrell, Emily E and Szagdaj, Anna and Poudel, Nabin and Wolpe, Abigail G and Thomas, Samantha H and Yeudall, Scott and Upchurch, Clint M and Okusa, Mark D and Isakson, Brant E and Wolf, Matthew J and Leitinger, Norbert},
  title = {Cardiomyocyte PANX1 Controls Glycolysis and Neutrophil Recruitment in Hypertrophy},
  journal = {Circulation Research},
  year = {2024},
  volume = {135},
  number = {4},
  pages = {503--517},
  doi = {10.1161/circresaha.124.324650}
}
Kostenlos starten →